Evidence map›Paper›PMID 28228284›Full record

ArticleImmunity2017

Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity.

Dania Zhivaki, Sébastien Lemoine, Annick Lim, Ahsen Morva, Pierre-Olivier Vidalain, Liliane Schandene, Nicoletta Casartelli, Marie-Anne Rameix-Welti, Pierre-Louis Hervé, Edith Dériaud and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 137 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Immune Response to Respiratory Viral Infections.International journal of molecular sciences · 2024
    Review
  20. Alterations in CX3CL1 Levels and Its Role in Viral Pathogenesis.International journal of molecular sciences · 2024
    Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 9 institutions in 3 countries.

Dania ZhivakiNeonatal Immunity Group, Human Histopathology and Animal Models, Institut Pasteur, Paris 75724, France; Paris 7 Diderot University, Paris 75724, France.
Sébastien LemoineRégulation Immunitaire et Vaccinologie, Institut Pasteur, Paris 75724, France; INSERM U1041, Paris 75724, France.
Annick LimDepartement d'Immunologie, Institut Pasteur, Paris 75724, France.
Ahsen MorvaNeonatal Immunity Group, Human Histopathology and Animal Models, Institut Pasteur, Paris 75724, France.
Pierre-Olivier VidalainUnité de Génomique virale et vaccination, Institut Pasteur, Paris 75724, France.
Liliane SchandeneImmunobiology Clinic, Hopital Erasme, Brussels 1070, Belgium.
Nicoletta CasartelliVirus et Immunité, Institut Pasteur, Paris 75724, France; UMR CNRS 3568, Paris 75724, France.
Marie-Anne Rameix-WeltiINSERM U1173, Versailles-Saint-Quentin University, Saint-Quentin en Yvelines 78180, France; AP-HP, Laboratoire de Microbiologie, Hôpital Ambroise Paré, Boulogne-Billancourt 92100, France.
Pierre-Louis HervéUnité de Virologie et Immunologie Moléculaires, INRA, Université Paris-Saclay, Jouy-en-Josas 78350, France.
Edith DériaudRégulation Immunitaire et Vaccinologie, Institut Pasteur, Paris 75724, France; INSERM U1041, Paris 75724, France.
Benoit BeitzBioaster Microbiology Technology Institute, Paris 75015, France.
Maryline Ripaux-LefevreBioaster Microbiology Technology Institute, Paris 75015, France.
Jordi MiatelloAPHP, Pediatric ICU and Neonatal Medicine, Paris South University Hospitals, Le Kremlin-Bicetre 94270, France; School of Medicine, Paris South University, Le Kremlin-Bicêtre 94270, France; Institute of Integrative Biology of the Cell - UMR 9196, Paris Saclay University, Gif-sur-Yvette 91190, France.
Brigitte LemercierDepartement d'Immunologie, Institut Pasteur, Paris 75724, France.
Valerie LorinLaboratory of Humoral Response to Pathogens, Department of Immunology, Institut Pasteur, Paris 75724, France; INSERM U1222, Paris 75724, France.
Delphyne DescampsUnité de Virologie et Immunologie Moléculaires, INRA, Université Paris-Saclay, Jouy-en-Josas 78350, France.
Jenna FixUnité de Virologie et Immunologie Moléculaires, INRA, Université Paris-Saclay, Jouy-en-Josas 78350, France.
Jean-François EléouëtUnité de Virologie et Immunologie Moléculaires, INRA, Université Paris-Saclay, Jouy-en-Josas 78350, France.
Sabine RiffaultUnité de Virologie et Immunologie Moléculaires, INRA, Université Paris-Saclay, Jouy-en-Josas 78350, France.
Olivier SchwartzVirus et Immunité, Institut Pasteur, Paris 75724, France; UMR CNRS 3568, Paris 75724, France.
Fabrice PorcherayBioaster Microbiology Technology Institute, Paris 75015, France.
Françoise MascartImmunobiology Clinic, Hopital Erasme, Brussels 1070, Belgium; Laboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles, Brussels 1070, Belgium.
Hugo MouquetLaboratory of Humoral Response to Pathogens, Department of Immunology, Institut Pasteur, Paris 75724, France; INSERM U1222, Paris 75724, France.
Xiaoming ZhangUnit of Innate Defense and Immune Modulation, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Pierre TissièresAPHP, Pediatric ICU and Neonatal Medicine, Paris South University Hospitals, Le Kremlin-Bicetre 94270, France; School of Medicine, Paris South University, Le Kremlin-Bicêtre 94270, France; Institute of Integrative Biology of the Cell - UMR 9196, Paris Saclay University, Gif-sur-Yvette 91190, France.
Richard Lo-ManNeonatal Immunity Group, Human Histopathology and Animal Models, Institut Pasteur, Paris 75724, France. Electronic address: richard.lo-man@pasteur.fr.
Institut Pasteur · FRUniversité Paris-Saclay · FRBIOASTER · FRErasmus Hospital · BEVirologie et Immunologie Moléculaires · FRCentre National de la Recherche Scientifique · FRInserm · FRInstitut Pasteur of Shanghai · CNUniversité de Versailles Saint-Quentin-en-Yvelines · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract infections in infants and is characterized by pulmonary infiltration of B cells in fatal cases. We analyzed the B cell compartment in human newborns and identified a population of neonatal regulatory B lymphocytes (nBreg cells) that produced interleukin 10 (IL-10) in response to RSV infection. The polyreactive B cell receptor of nBreg cells interacted with RSV protein F and induced upregulation of chemokine receptor CX3CR1. CX3CR1 interacted with RSV glycoprotein G, leading to nBreg cell infection and IL-10 production that dampened T helper 1 (Th1) cytokine production. In the respiratory tract of neonates with severe RSV-induced acute bronchiolitis, RSV-infected nBreg cell frequencies correlated with increased viral load and decreased blood memory Th1 cell frequencies. Thus, the frequency of nBreg cells is predictive of the severity of acute bronchiolitis disease and nBreg cell activity may constitute an early-life host response that favors microbial pathogenesis.

Indexed as

B-Lymphocytes, RegulatoryBronchiolitis, ViralCD4-Positive T-LymphocytesCX3C Chemokine Receptor 1Enzyme-Linked Immunosorbent AssayEnzyme-Linked Immunospot AssayGene Expression ProfilingHumansInfant, NewbornLymphocyte ActivationOligonucleotide Array Sequence AnalysisReceptors, ChemokineRespiratory Syncytial VirusesRespiratory Syncytial Virus InfectionsTranscriptomeCX3C Chemokine Receptor 1CX3CR1 protein, humanReceptors, ChemokineBreg cellbronchiolitisnewbornrespiratory syncytial virus

Identifiers

PMID28228284
PMCPMC7128247
OpenAlexW2589772520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.